These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 15190415)
1. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1). Hermanová M; Lukás Z; Nenutil R; Brázdil J; Kroupová I; Kren L; Pazourková M; Růzicka M; Díte P Neoplasma; 2004; 51(2):77-83. PubMed ID: 15190415 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405 [TBL] [Abstract][Full Text] [Related]
3. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma. Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083 [TBL] [Abstract][Full Text] [Related]
4. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast. Latta EK; Tjan S; Parkes RK; O'Malley FP Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013 [TBL] [Abstract][Full Text] [Related]
5. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material. Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540 [TBL] [Abstract][Full Text] [Related]
6. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization. Dancer J; Takei H; Ro JY; Lowery-Nordberg M Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361 [TBL] [Abstract][Full Text] [Related]
7. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215 [TBL] [Abstract][Full Text] [Related]
8. HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis. Tsiambas E; Karameris A; Dervenis C; Lazaris AC; Giannakou N; Gerontopoulos K; Patsouris E JOP; 2006 May; 7(3):283-94. PubMed ID: 16685109 [TBL] [Abstract][Full Text] [Related]
9. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer. Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097 [TBL] [Abstract][Full Text] [Related]
10. ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression. Yang W; Klos KS; Zhou X; Yao J; Yang Y; Smith TL; Shi D; Yu D Cancer; 2003 Sep; 98(6):1123-30. PubMed ID: 12973835 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. Xia W; Chen JS; Zhou X; Sun PR; Lee DF; Liao Y; Zhou BP; Hung MC Clin Cancer Res; 2004 Jun; 10(11):3815-24. PubMed ID: 15173090 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L; Sanderson SO; Lloyd RV; Smyrk TC Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [TBL] [Abstract][Full Text] [Related]
13. Role of immunohistochemical identification of Her-2/neu and detection of variability in overexpression in pancreatic carcinoma. Koka V; Potti A; Koch M; Fraiman G; Mehdi S; Levitt R Anticancer Res; 2002; 22(3):1593-7. PubMed ID: 12168842 [TBL] [Abstract][Full Text] [Related]
14. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Adsay NV; Basturk O; Cheng JD; Andea AA Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479 [TBL] [Abstract][Full Text] [Related]
15. Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells. Ito D; Fujimoto K; Doi R; Koizumi M; Toyoda E; Mori T; Kami K; Kawaguchi Y; Whitehead R; Imamura M Surgery; 2004 Aug; 136(2):364-74. PubMed ID: 15300203 [TBL] [Abstract][Full Text] [Related]
16. p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer. Ahrendt SA; Brown HM; Komorowski RA; Zhu YR; Wilson SD; Erickson BA; Ritch PS; Pitt HA; Demeure MJ Surgery; 2000 Oct; 128(4):520-30. PubMed ID: 11015084 [TBL] [Abstract][Full Text] [Related]
17. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma]. Tomaszewska R Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling. McCarthy DM; Brat DJ; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH Hum Pathol; 2001 Jun; 32(6):638-42. PubMed ID: 11431719 [TBL] [Abstract][Full Text] [Related]
19. Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. Lee KM; Cao D; Itami A; Pour PM; Hruban RH; Maitra A; Ouellette MM Histopathology; 2007 Oct; 51(4):539-46. PubMed ID: 17714470 [TBL] [Abstract][Full Text] [Related]
20. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]